(Q73168752)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11070171%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11070171%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

J E Slansky

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11070171%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

F M Rattis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11070171%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

L F Boyd

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11070171%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

T Fahmy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11070171%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

E M Jaffee

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11070171%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

J P Schneck

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11070171%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

D H Margulies

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11070171%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

D M Pardoll

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11070171%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 October 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11070171%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11070171%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11070171%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

529-538

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11070171%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11070171%20AND%20SRC:MED&resulttype=core&format=json

T-cell-receptor affinity and thymocyte positive selection

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Definition of TCR recognition sites on Ld-tum- complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Analogues of CTL epitopes with improved MHC class-I binding capacity elicit anti-melanoma CTL recognizing the wild-type epitope

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

The three-dimensional structure of an H-2Ld-peptide complex explains the unique interaction of Ld with beta-2 microglobulin and peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Tumor antigens recognized by T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Solution binding of an antigenic peptide to a major histocompatibility complex class I molecule and the role of beta 2-microglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Mimotopes of cytolytic T lymphocytes in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Functional three-domain single-chain T-cell receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Ligand recognition by alpha beta T cell receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Identification of genes coding for tumor antigens recognized by cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Heteroclitic immunization induces tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

The makings of a tumor rejection antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Naive alloreactive CD8 T cells are activated by purified major histocompatibility complex class I and antigenic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

A colon tumor model for anticancer agent evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Murine tumor antigens: is it worth the search?

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Measuring interactions of MHC class I molecules using surface plasmon resonance

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

A bacterially expressed single-chain Fv construct from the 2B4 T-cell receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Soluble, High-Affinity Dimers of T-Cell Receptors and Class II Major Histocompatibility Complexes: Biochemical Probes for Analysis and Modulation of Immune Responses

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Three-dimensional structure of H-2Dd complexed with an immunodominant peptide from human immunodeficiency virus envelope glycoprotein 120

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Structure of the gene of tum- transplantation antigen P91A: the mutated exon encodes a peptide recognized with Ld by cytolytic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Binding energetics of T-cell receptors: correlation with immunological consequences

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

MHC class I/peptide interactions: binding specificity and kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Studying interactions involving the T-cell antigen receptor by surface plasmon resonance

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

The bacterial and mouse mammary tumor virus superantigens; two different families of proteins with the same functions.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Analysis of the expression of peptide-major histocompatibility complexes using high affinity soluble divalent T cell receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Therapeutic vaccination for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Human tumor antigens recognized by T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

A kinetic basis for T cell receptor repertoire selection during an immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

T-lymphocyte response to cytochrome c. I. Demonstration of a T-cell heteroclitic proliferative response and identification of a topographic antigenic determinant on pigeon cytochrome c whose immune recognition requires two complementing major histoc

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Structural basis of 2C TCR allorecognition of H-2Ld peptide complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2900052-2

7 January 2021

10.1016/S1074-7613(00)00052-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11070171%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference